Author

A. Wellstein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

M. O. Schmidt· 2 shared A. D. Mays· 1 shared A. J. Kiliti· 1 shared A. P. McDeed· 1 shared A. T. Dominguez· 1 shared A. T. Riegel· 1 shared C. Lewis· 1 shared D. Gallego-Ortega· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. O. Schmidt

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Tumour specimen cold ischemia time impacts molecular cancer drug target discovery

S. von der Heyde, N. Raman, N. Gabelia, X. Matias-Guiu, T. Yoshino, Y. Tsukada, G. Melino, J. L. Marshall, A. Wellstein, H. Juhl, J. Landgrebe

This study shows that cold ischemia time significantly affects molecular profiles in tumor and normal tissues, impacting drug target discovery.

bioRxiv · May 23, 2024 · PreprintCancer Biology

Pleiotrophin drives a pro-metastatic immune niche within the breast tumor microenvironment

D. Ganguly, M. O. Schmidt, M. Coleman, T.-V. Ngo, N. Sorrelle, A. T. Dominguez, J. Toombs, C. Lewis, Y. Fang, F. V. Mora, D. Gallego-Ortega, A. Wellstein, R. A. Brekken

This study identifies pleiotrophin as a driver of a pro-metastatic immune niche in breast cancer, showing its role in immune suppression and metastasis, and highlights its potential as a therapeutic target.

bioRxiv · May 2, 2022Cancer Biology

Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

M. E. Barefoot, N. Loyfer, A. J. Kiliti, M. O. Schmidt, S. Shabi-Porat, S. Jain, S. M. Roth, A. P. McDeed, N. Shahrour, E. Ballew, Y.-T. Lin, H.-H. Li, A. D. Mays, S. Rudra, A. T. Riegel, , A. Wellstein

This study uses cell-free methylated DNA in blood to detect tissue-specific damage from radiation treatment in mice and cancer patients.

bioRxiv · Apr 12, 2022Cancer Biology